Atlas Trials

MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma

Clinical trial NCT04216953 · COMPLETED

Trial details

NCT number
NCT04216953
Sponsor
Centre Leon Berard
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Sarcoma,Soft Tissue
Start date
2020-02-12
Primary completion
2024-12-01
Enrollment
229

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.